Equity (Tables)

9 Months Ended

Sep. 30, 2022

Schedule of Stockholders' Equity Note, Warrants or Rights

The following table summarizes all warrants outstanding as of September 30, 2022:


Expiration Date	Exercise Price ($)	Number of Warrants
2023	1.47 - 1.50	337,500
2024	1.25	35,862,922
2025	1.25 - 3.00	2,168,508
2026	4.18	300,000
2027	1.93	300,000
2029	0.50 - 2.00	26,367,627
Total warrants		65,336,557

The following table summarizes the status of warrants and related transactions:


	Non-Derivative Warrants	Derivative Warrants (2)	Total Number of Warrants	Weighted - Average Exercise Price






Balance as of January 1, 2022	29,156,048	40,124,355	69,280,403	$	1.19
Granted	400,000	—	400,000	$	2.20
Exercised (1)	(715,846)	(3,628,000)	(4,343,846)	$	1.26



Balance as of September 30, 2022	28,840,202	36,496,355	65,336,557	$	1.19
Exercisable as of September 30, 2022	26,940,202	36,496,355	63,436,557	$	1.15

(1)The weighted average share price as of the dates of exercise was $3.51. The Company issued 3,176,601 SVS and received $1,179 in cash proceeds during the nine months ended September 30, 2022 for warrants exercised.

(2)Derivative warrants which were issued to the Senior Notes holders and which have an exercise price of $1.25. These warrants represent a derivative liability and are therefore not classified as equity in the statement of financial position. Refer to Note 12 - Derivative Liabilities.